Estimating the full health and economic benefits of current and future influenza vaccines

In the dynamic landscape of respiratory virus vaccines, it is crucial to assess the value of novel mRNA and combination influenza/COVID-19 vaccines in low- and middle-income countries. Modeling studies, such as the one conducted by Waterlow et al., provide vital information about the cost–benefit po...

Descripción completa

Detalles Bibliográficos
Autores principales: Lafond, K. E., Gharpure, R., Dugan, V. G., Azziz-Baumgartner, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373290/
https://www.ncbi.nlm.nih.gov/pubmed/37501176
http://dx.doi.org/10.1186/s12916-023-02995-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373290/
https://www.ncbi.nlm.nih.gov/pubmed/37501176
http://dx.doi.org/10.1186/s12916-023-02995-4

Ejemplares similares